Author

Ben Guenther

Observed name: B Guenther

Institutions: Emergent BioSolutions (United States), Bavarian Nordic (United States)

Observed institutions: Emergent BioSolutions (United States), PaxVax (United States), Bavarian Nordic (United States)

ORCID: 0000-0002-4127-7079

Observed ORCID: 0000-0002-4127-7079

OpenAlex ID: A5058396434

Pre-Clinical Evaluation of a Replication-Competent Recombinant Adenovirus Serotype 4 Vaccine Expressing Influenza H5 Hemagglutinin

2012 · Jeff Alexander, Simone Ward, et al. · PLoS ONE · 63

Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge

2017 · Diego Espinosa, Jason Mendy, et al. · EBioMedicine · 59

Zika virus-like particle vaccine protects AG129 mice and rhesus macaques against Zika virus

2021 · Lo Vang, Christopher S. Morello, et al. · PLoS neglected tropical diseases · 29

Zika virus-like particle vaccine fusion loop mutation increases production yield but fails to protect AG129 mice against Zika virus challenge

2022 · Danielle Thompson, Ben Guenther, et al. · PLoS neglected tropical diseases · 8

Passive transfer of human sera from chikungunya virus virus-like particle vaccine (Vimkunya) recipients fully protects non-human primates from viremia

2026 · Christopher S. Morello, Ravi Anantha, et al. · npj Vaccines · 5

A chikungunya virus-like particle vaccine reduces chikungunya disease in cynomolgus macaques and protection is mediated by antibody transferred from vaccinated humans

2026 · Lark L. Coffey, Katherine J. Olstad, et al. · npj Vaccines · 2

Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein

2012 · J Alexander, M Gurwith, et al. · Retrovirology · 1

Works count: 7

Citation count: 167

H-index: 5

I10-index: 3